NCT07176910

Brief Summary

the study is to evaluated dopplar guided angiopuncture efficacy and safety in patients with dysmenorrhea

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2024

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

September 7, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

September 16, 2025

Completed
15 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2025

Completed
Last Updated

September 16, 2025

Status Verified

September 1, 2025

Enrollment Period

1.1 years

First QC Date

September 7, 2025

Last Update Submit

September 12, 2025

Conditions

Keywords

Dysmenorrheaangiopuncturedopplarultrasound

Outcome Measures

Primary Outcomes (1)

  • visual analog scale

    to measure pain score before and after angiopuncture

    pre-treatment, immediate post-treatment, check up 1, check up 2, check up 3 (3 check ups lasts for 3 months post therapy, with each for 1 month)

Study Arms (1)

angiopuncture treated group

EXPERIMENTAL

conduct angiopuncture therapy

Other: conduct angiopuncture on perforator points

Interventions

conducted angiopuncutre on patients of intervention group, and compare those patients pain scores before and after angiopuncture therapy.

angiopuncture treated group

Eligibility Criteria

Age18 Years - 25 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsSince we studied dysmenorrhea, we recuited nmarried nulliparous women.
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Primary dysmenorrhea diagnosis (≥6 months of menstrual pain scoring ≥2 on numerical rating scale) Regular menstrual cycles (28-32 days), menstrual period lasts 4 to 7 days No pelvic pathology on transvaginal ultrasound.

You may not qualify if:

  • coagulopathy (INR \>1.5) recent analgesic use (48-hour washout) secondary dysmenorrhea confirmed by laparoscopy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Third Affiliated Hospital of Changchun University of Chinese Medicine

Changchun, China

RECRUITING

MeSH Terms

Conditions

Dysmenorrhea

Condition Hierarchy (Ancestors)

Menstruation DisturbancesPathologic ProcessesPathological Conditions, Signs and SymptomsPelvic PainPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Jinlian HU, PhD

    City University of Hong Kong

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Rong HAN, PhD student

CONTACT

Yuenkei LEE, Mphil

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: unmarried nulliparous women (aged 18-25 years old) with dysmenorrhea diagnosis
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD student

Study Record Dates

First Submitted

September 7, 2025

First Posted

September 16, 2025

Study Start

September 1, 2024

Primary Completion

October 1, 2025

Study Completion

November 1, 2025

Last Updated

September 16, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

we have not published the paper yet

Locations